Repligen (RGEN) Purchases Bioprocessing Analytics Portfolio from 908 Devices (MASS)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Wall St on pace for higher open as oil pulls back ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
| (NASDAQ: MASS) | Delayed: 11.65 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $11.65 | 52 Week High | $ | |||
| Open | $11.91 | 52 Week Low | $ | |||
| Day High | $11.91 | P/E | N/A | |||
| Day Low | $11.64 | EPS | $ | |||
| Volume | 40,091 | |||||
| Repligen Corp (NASDAQ: RGEN) | Delayed: 171.33 -8.84 (4.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $180.17 | 52 Week High | $33.79 | |||
| Open | $168.34 | 52 Week Low | $20.07 | |||
| Day High | $174.89 | P/E | 244.76 | |||
| Day Low | $164.88 | EPS | $0.70 | |||
| Volume | 335,051 | |||||
